U.S. Buys The World’s Supply Of Breakthrough Coronavirus Drug Remdesivir


Alex Azar, United States Secretary of Health and Human Services boasted of President Trump’s “amazing deal” that has bought the world’s entire supply of Gilead Sciences’ Remdesivir, a drug that some research suggests could speed the recovery of coronavirus patients.

The U.S. government will buy 100% of the California-based pharmaceutical company’s production in July, 90% of output in August and September in a move that should provide enough Remdesivir to treat around 80,000 patients. The deal between the U.S. government and Gilead means that low and middle-income countries can make their own generic version of Remdesivir, but European, and other, countries will be unable to buy, or produce it. Remdesivir sells for $390 per vial, or $2,340 per course of treatment sparking a backlash from consumer groups over its pricing pointing to $70 million of U.S. taxpayers’ support for Gilead’s development of the drug.


Gilead in May donated its entire stockpile of the drug, which was originally developed to treat hepatitis and respiratory viruses, to the U.S. government but doctors have faced having to ration the limited supply for the most needy patients, according to CNN.

Early research shows that the drug speeds recovery time for patients severely ill with coronavirus to 11 days from 15 days for those in the control group.



“President Trump has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19,” said HHS Secretary Alex Azar in a statement. “To the extent possible, we want to ensure that any American patient who needs Remdesivir can get it.

Key background

The Federal Drug Administration authorized emergency approval in May for the antiviral drug in May after early research showed that it could help patients infected with coronavirus recover faster.

The battle for access to a potentially crucial treatment plays out against the backdrop of Europe’s recovery from the pandemic, a surge of new infections in the U.S., and President Donald Trump’s reflexive nativism. The Trump administration’s trade war and diplomacy has repeatedly taxed even some of the U.S’s most long standing alliances, and the White House’s attempt in March to lure German company CuraVac to produce a coronavirus vaccine exclusively for Americans with financial incentives caused uproar.


The U.S. has been the world’s worst affected nation and as 47,000 new cases of coronavirus were reported on Tuesday, the worst single day since the start of the pandemic, according to the New York Times.

Send me a secure tip.

I joined Forbes as the European News Editor and will be working with the London newsroom to define our coverage of emerging businesses and leaders across the UK and Europe. Prior to joining Forbes, I worked for the news agency Storyful as its Asia Editor working from its Hong Kong bureau, and as a Senior Editor in London, where I reported on breaking news stories from around the world, with a special focus on how misinformation and disinformation spreads on social media platforms. I started my career in London as a financial journalist with Citywire and my work has appeared in the BBC, Sunday Times, and many more UK publications. Email me story ideas, or tips, to iain.martin@forbes.com, or Twitter @_iainmartin.

Source: http://www.forbes.com

The US has bought up virtually all stocks of a drug shown to work against Covid-19 – raising fears Brits won’t be able to get hold of it until autumn. The decision by the Trump administration has sparked fury with leading scientists who have raised concerns over “fair access” to remdesivir. The anti-viral drug was originally developed for use against Ebola but trials showed that it helped patients hospitalised with coronavirus recover almost a third faster. Health Secretary Matt Hancock hailed it the “biggest step forward” in treating Covid-19 when it was given approval for use on the NHS in May.
But now there are concerns patients in the UK won’t get widespread access to the treatment after the US bought more than 500,000 doses. It makes up the entire global supply for July and 90 per cent of stocks for August and September. Read more Trump buys up ENTIRE stock of coronavirus drug remdesivir – sparking fury among medics https://www.thesun.co.uk/news/1199617…
From Brexit breaking news to HD movie trailers, The Sun newspaper brings you the latest news videos and explainers from the UK and around the world. Become a Sun Subscriber and hit the bell to be the first to know Read The Sun: http://www.thesun.co.uk Like The Sun on Facebook: https://www.facebook.com/thesun/
Follow The Sun on Twitter: https://twitter.com/TheSun
Subscribe to The Sun on Snapchat: https://www.snapchat.com/discover/The…

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: